Notice of Annual General Meeting of Shareholders in NeuroVive Pharmaceutical AB
(WorldNews Sweden)

Notice of Annual General Meeting of Shareholders in NeuroVive Pharmaceutical AB The Board of Directors of NeuroVive Pharmaceutical AB (publ) has issued a notice to the Annual General Meeting, which is to take place on Thursday, April 27, 2017, at 4 pm at Medicon Village, Scheelevägen 2 in Lund, Sweden. Please see the attached notification, which is being announced within short in Svenska Dagbladet and Post- och Inrikes Tidningar. Lund, March 23, 2017 NeuroVive Pharmaceutical AB (PUBL) THE BOARD OF DIRECTORS About NeuroVive NeuroVive Pharmaceutical AB is a leader in mitochondrial medicine. The company is committed to the discovery and development of medicines that preserve mitochondrial...